GlassScriptPhysician profile
Luis A Jaramillo
NPI 1063506905
$1,365.92
in general payments reported to CMS, 2019-2025
22 companies · $430 in 2025
The $430 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.86 · 2020: $188 · 2021: $72.82 · 2022: $287 · 2023: $137 · 2024: $189 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $756.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $261.75 | 2020-2024 | |
| Vertex Pharmaceuticals Incorporated | $202.88 | 2025 | |
| Sientra, INC. | $142.79 | 2020-2022 | |
| Pacira Pharmaceuticals Incorporated | $125.68 | 2019-2025 | Exparel |
| Integra Lifesciences Corporation | $81.75 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Aroa Biosurgery Incorporated | $62.76 | 2022-2025 | |
| Mentor Worldwide LLC | $60.63 | 2019-2020 | |
| Abbvie INC. | $52.70 | 2023-2025 | |
| Kerecis Limited | $43.11 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Tela Bio, INC. | $42.61 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Convatec INC. | $38.98 | 2023-2024 | |
| Solventum Corporation | $36.22 | 2024-2025 | Activ.A.C. |
| Smith+Nephew, INC. | $35.93 | 2021 | |
| Polynovo North America LLC | $32.78 | 2025 | Novosorb Btm |
| Kowa Pharmaceuticals America, INC. | $24.87 | 2023 | Seglentis |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $23.33 | 2025 | Restrata Wound Matrix |
| Allergan, INC. | $22.52 | 2020 | |
| Avanos Medical | $18.56 | 2020 | |
| Davol INC. | $18.10 | 2023 | Arista Ah Flexitip |
| Bioventus LLC | $14.02 | 2025 | Bonescalpel & Sonicone (O.R.) |
| Galderma Laboratories, L.P. | $12.42 | 2019 | |
| Innovation Technologies INC | $11.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Jaramillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.